Sanchez Y, Wong C, Thoma R S, Richman R, Wu Z, Piwnica-Worms H, Elledge S J
Verna and Marrs McLean Department of Biochemistry, Howard Hughes Medical Institute, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.
Science. 1997 Sep 5;277(5331):1497-501. doi: 10.1126/science.277.5331.1497.
In response to DNA damage, mammalian cells prevent cell cycle progression through the control of critical cell cycle regulators. A human gene was identified that encodes the protein Chk1, a homolog of the Schizosaccharomyces pombe Chk1 protein kinase, which is required for the DNA damage checkpoint. Human Chk1 protein was modified in response to DNA damage. In vitro Chk1 bound to and phosphorylated the dual-specificity protein phosphatases Cdc25A, Cdc25B, and Cdc25C, which control cell cycle transitions by dephosphorylating cyclin-dependent kinases. Chk1 phosphorylates Cdc25C on serine-216. As shown in an accompanying paper by Peng et al. in this issue, serine-216 phosphorylation creates a binding site for 14-3-3 protein and inhibits function of the phosphatase. These results suggest a model whereby in response to DNA damage, Chk1 phosphorylates and inhibits Cdc25C, thus preventing activation of the Cdc2-cyclin B complex and mitotic entry.
作为对DNA损伤的反应,哺乳动物细胞通过控制关键的细胞周期调节因子来阻止细胞周期进程。人们鉴定出了一个人类基因,它编码Chk1蛋白,Chk1蛋白是粟酒裂殖酵母Chk1蛋白激酶的同源物,而粟酒裂殖酵母Chk1蛋白激酶是DNA损伤检查点所必需的。人类Chk1蛋白会因DNA损伤而发生修饰。在体外,Chk1与双特异性蛋白磷酸酶Cdc25A、Cdc25B和Cdc25C结合并使其磷酸化,这些双特异性蛋白磷酸酶通过使细胞周期蛋白依赖性激酶去磷酸化来控制细胞周期转换。Chk1使Cdc25C的丝氨酸-216位点磷酸化。正如彭等人在本期发表的一篇相关论文中所表明的,丝氨酸-216位点的磷酸化形成了一个14-3-3蛋白的结合位点,并抑制了该磷酸酶的功能。这些结果提示了一个模型,即作为对DNA损伤的反应,Chk1使Cdc25C磷酸化并抑制其功能,从而阻止Cdc2-细胞周期蛋白B复合物的激活以及有丝分裂的进入。